Clinical value of CT-guided radioactive I particle implantation combined with SrCl in relieving pain after failure of external irradiation in patients with prostate cancer bone metastases.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
48 patients (aged, 56-85 years) with prostate cancer bone metastases admitted to the Department of Nuclear Medicine of the General Hospital of Northern Theatre Command from January 2019 to December 2023 were retrospectively analyzed.
I · Intervention 중재 / 시술
I seeds implantation brachytherapy combined with SrCl treatment (Group A), and SrCl treatment alone (Group B)
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] CT-guided radioactive I seeds implantation combined with SrCl for the treatment of pain after failure of external irradiation in patients with prostate cancer bone metastases, is a feasible and effective treatment. The effect is relatively significant for breakthrough pain, which improves the quality of life of patients with bone metastasis-related pain.
[PURPOSE] To evaluate the feasibility and clinical value of computed tomography (CT)-guided radioactive iodine-125 (I) seeds implantation combined with strontium chloride (SrCl) in relieving pain afte
APA
Ji L, Zhang W, et al. (2025). Clinical value of CT-guided radioactive I particle implantation combined with SrCl in relieving pain after failure of external irradiation in patients with prostate cancer bone metastases.. Journal of contemporary brachytherapy, 17(5), 322-332. https://doi.org/10.5114/jcb.2025.156049
MLA
Ji L, et al.. "Clinical value of CT-guided radioactive I particle implantation combined with SrCl in relieving pain after failure of external irradiation in patients with prostate cancer bone metastases.." Journal of contemporary brachytherapy, vol. 17, no. 5, 2025, pp. 322-332.
PMID
41340833 ↗
Abstract 한글 요약
[PURPOSE] To evaluate the feasibility and clinical value of computed tomography (CT)-guided radioactive iodine-125 (I) seeds implantation combined with strontium chloride (SrCl) in relieving pain after failure of external irradiation in patients with prostate cancer bone metastases.
[MATERIAL AND METHODS] Clinical data of 48 patients (aged, 56-85 years) with prostate cancer bone metastases admitted to the Department of Nuclear Medicine of the General Hospital of Northern Theatre Command from January 2019 to December 2023 were retrospectively analyzed. They underwent I seeds implantation brachytherapy combined with SrCl treatment (Group A), and SrCl treatment alone (Group B).
[RESULTS] A total of 722 seeds were implanted in 39 bone metastases of 23 patients in group A; the implantation success rate was 97.44% (38/39), while there were 25 patients in group B. The worst pain, average pain, and present pain scores of group A decreased over time (-values: 22.47, 5.22, 3.71; -values: < 0.001, 0.001, 0.007), and the differences in the worst pain, average pain, and present pain scores compared with before treatment were statistically significant at 12 weeks after treatment (-values: 6.14, 3.36, 2.86; -values: < 0.001, 0.002, 0.007). The worst pain at 3 days, 4 weeks, 8 weeks, and 12 weeks after treatment was not statistically significant compared with pre-treatment ( = 2.01, = 0.0501), while statistical significance was observed at the remaining 4 weeks, 8 weeks, and 12 weeks ( = 7.11, 5.31, 6.14; all < 0.0001). Also, differences in the worst pain, average pain, and present pain scores of group B before and after treatment were documented.
[CONCLUSIONS] CT-guided radioactive I seeds implantation combined with SrCl for the treatment of pain after failure of external irradiation in patients with prostate cancer bone metastases, is a feasible and effective treatment. The effect is relatively significant for breakthrough pain, which improves the quality of life of patients with bone metastasis-related pain.
[MATERIAL AND METHODS] Clinical data of 48 patients (aged, 56-85 years) with prostate cancer bone metastases admitted to the Department of Nuclear Medicine of the General Hospital of Northern Theatre Command from January 2019 to December 2023 were retrospectively analyzed. They underwent I seeds implantation brachytherapy combined with SrCl treatment (Group A), and SrCl treatment alone (Group B).
[RESULTS] A total of 722 seeds were implanted in 39 bone metastases of 23 patients in group A; the implantation success rate was 97.44% (38/39), while there were 25 patients in group B. The worst pain, average pain, and present pain scores of group A decreased over time (-values: 22.47, 5.22, 3.71; -values: < 0.001, 0.001, 0.007), and the differences in the worst pain, average pain, and present pain scores compared with before treatment were statistically significant at 12 weeks after treatment (-values: 6.14, 3.36, 2.86; -values: < 0.001, 0.002, 0.007). The worst pain at 3 days, 4 weeks, 8 weeks, and 12 weeks after treatment was not statistically significant compared with pre-treatment ( = 2.01, = 0.0501), while statistical significance was observed at the remaining 4 weeks, 8 weeks, and 12 weeks ( = 7.11, 5.31, 6.14; all < 0.0001). Also, differences in the worst pain, average pain, and present pain scores of group B before and after treatment were documented.
[CONCLUSIONS] CT-guided radioactive I seeds implantation combined with SrCl for the treatment of pain after failure of external irradiation in patients with prostate cancer bone metastases, is a feasible and effective treatment. The effect is relatively significant for breakthrough pain, which improves the quality of life of patients with bone metastasis-related pain.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Targeting magnesium homeostasis: a novel therapeutic strategy for liver diseases.
- Article title: Associations between paraben exposure and breast cancer risk: An integrative epidemiologic, network toxicology, multi-omics and experimental analysis.
- Comprehensive multi-omics data to construct hepatocellular carcinoma pathway subtypes and classification model.
- A live biohybrid bacterial therapy based on engineered Serratia marcescens.
- High extracellular matrix stiffness upregulates TNNT1 to awaken dormant tumor cells in liver metastatic niches of gastric cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Prospective Evaluation of Irreversible Electroporation With Clustered Electrodes as a Novel Palliative Approach for Locally Advanced Pancreatic Cancer.
- Analgesic efficacy in women and men with cancer pain, treated with strong opioids: are there differences?
- Efficacy of haemostatic radiotherapy for bleeding related to nonoperable advanced gastric cancer.
- Utilization of palliative care services and associated factors among cancer patients in Ethiopia: A systematic review and meta-analysis.
- Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell Carcinoma.
- Extracellular Vesicles from Osteotropic Triple-Negative Breast Cancer Cells Transfer miRNAs to Bone Cells Reducing Collagen Expression and Bone Matrix Mineralisation.